Distinguished in Bladder Cancer

Stephane Culine

Paris, FR 
Distinguished in Bladder Cancer
Paris, FR 
OverviewLocationsClinical Research

Overview

Stephane Culine practices in Paris, France. Ms. Culine is rated as a Distinguished expert by MediFind in the treatment of Bladder Cancer. Her top areas of expertise are Bladder Cancer, Urothelial Cancer, Prostate Cancer, Orchiectomy, and Cystectomy.

Her clinical research consists of co-authoring 284 peer reviewed articles and participating in 4 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, she has co-authored 73 articles in the study of Bladder Cancer.

Gender
Female

Locations

Paris, France
Other Locations
Rouen, France
Creteil, France
Hôpital St Andre
Bordeaux, France
Port-saint-louis-du-rhone, France
Mareuil-les-meaux, 77100, France
CRLC Val d'Aurelle
Montpellier, France
Cedex
Val-de-la-haye, France

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

4 Clinical Trials

Personalized Treatment of Metastatic Castrate Resistant Prostate Cancer Patients According to Circulating Tumor Cells Kinetic During Chemotherapy: A GETUG-AFU 28 Study
Personalized Treatment of Metastatic Castrate Resistant Prostate Cancer Patients According to Circulating Tumor Cells Kinetic During Chemotherapy: A GETUG-AFU 28 Study
Enrollment Status: Completed
Publish Date: February 10, 2022
Intervention Type: Drug
Study Drugs: Cabazitaxel, Docetaxel
Study Phase: Phase 2
Prospective Multicentric Evaluation of a Bladder Preservation Strategy Using a Combination of Neoadjuvant Chemotherapy and Optimal Bladder Transurethral Resection in Patients With a Urothelial Carcinoma
Prospective Multicentric Evaluation of a Bladder Preservation Strategy Using a Combination of Neoadjuvant Chemotherapy and Optimal Bladder Transurethral Resection in Patients With a Urothelial Carcinoma
Enrollment Status: Terminated
Publish Date: December 30, 2021
Intervention Type: Drug
Study Drug: Optimal TURB
Study Phase: Phase 2
A Randomized, Multicenter, Open-label, Phase II Study of the Optimal Scheme of Administration of Pazopanib in Thyroid Carcinoma
A Randomized, Multicenter, Open-label, Phase II Study of the Optimal Scheme of Administration of Pazopanib in Thyroid Carcinoma
Enrollment Status: Completed
Publish Date: August 16, 2019
Intervention Type: Drug
Study Phase: Phase 2
A First in Human Phase I Study of INVAC-1 as a Single Agent in Patients With Advanced Cancer
A First in Human Phase I Study of INVAC-1 as a Single Agent in Patients With Advanced Cancer
Enrollment Status: Completed
Publish Date: February 26, 2019
Intervention Type: Biological
Study Phase: Phase 1
View 3 Less Clinical Trials

284 Total Publications

Cooperation between hematologists and geriatricians
Cooperation between hematologists and geriatricians
Journal: Soins. Gerontologie
Published: November 13, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Ms. Culine's expertise for a condition
ConditionClose
    View All 15 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile